CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED (02877) reported no changes to its authorized share capital or issued shares as of October 31, 2025. The company's authorized share capital remained at HKD 500,000,000, comprising 5,000,000,000 ordinary shares at a par value of HKD 0.1 each. Issued shares remained at 827,000,000, and no treasury shares were reported. No movements were disclosed for share options, warrants, convertibles, or any similar arrangements during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments